R1 RCM Inc

R1 RCM — FY2022 Earnings Presentation

10 slides from R1 RCM's earnings presentation, Feb 16, 2023

  1. Slide 1: Fourth Quarter and Full Year 2022 Earnings Call

    February 16, 2023 Fourth Quarter and Full Year 2022 Earnings Call

  2. Slide 2: Forward-Looking Statements

    22 Forward-Looking Statements This presentation includes information that may constitute “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-lookin

  3. Slide 3: Today's Discussion Topics

    33 Today's Discussion Topics Operational Execution • Exceeded 2022 targets by signing over $13B in end-to-end NPR, 15 large physician groups, and over 600 distinct modular solution bookings • Integrated legacy teams under Kyle Hicok's leadership • Grew pipeline to advance relationships across all so

  4. Slide 4: 4Q'22/FY'22 Results and 2023 Guidance

    44 4Q'22/FY'22 Results and 2023 Guidance Fourth Quarter 2022 Results • Revenue of $1,806.4 million, up $331.8 million or 22.5% compared to 2021 • GAAP net loss of $57.6 million, compared to net income of $97.2 million in 2021 • Adjusted EBITDA1 of $425.5 million, up $81.9 million or 23.8% compared t

  5. Slide 5: 4Q'22 GAAP and Non-GAAP Results: Q/Q and Y/Y Comparison

    55 4Q'22 GAAP and Non-GAAP Results: Q/Q and Y/Y Comparison ($ in millions) 4Q'22 3Q'22 4Q'21 Key Change Driver(s) Revenue $532.8 $496.0 $398.9 • Q/Q: New customers, modular growth and higher incentive fees due to incremental operational efforts • Y/Y: Contribution from Cloudmed and new customers, pa

  6. Slide 6: Full Year 2022 GAAP and Non-GAAP Results: Y/Y Comparison

    66 Full Year 2022 GAAP and Non-GAAP Results: Y/Y Comparison ($ in millions) 2022 2021 Y/Y Change Key Change Driver(s) Revenue $1,806.4 $1,474.6 22.5% • Contribution from Cloudmed and new end-to-end customers, partially offset by lower incentive fees Adjusted Cost of Services1 $1,245.5 $1,043.9 19.3%

  7. Slide 7: Additional Commentary

    77 Additional Commentary Cash Flow and Balance Sheet Highlights • Expect Q1 2023 adjusted EBITDA1 to grow approximately 5% relative to Q4 2022 Q1’23 Outlook Note1: Net debt and adjusted EBITDA are non-GAAP measures; refer to the Appendix for a reconciliation of non-GAAP financial measures Note2: Inc

  8. Slide 8: Appendix

    endix p Ap ) ol

  9. Slide 9: Use of Non-GAAP Financial Measures

    99 Use of Non-GAAP Financial Measures Reconciliation of GAAP Operating Income Guidance to Non-GAAP Adjusted EBITDA Guidance $ in millions  In order to provide a more comprehensive understanding of the information used by R1’s management team in financial and operational decision making, the Company

  10. Slide 10: Reconciliation of Non-GAAP Financial Measures

    1010 Reconciliation of Non-GAAP Financial Measures $ in millions Reconciliation of GAAP Net Income (Loss) to Non-GAAP Adjusted EBITDA Three Months Ended December 31, Year Ended December 31, Three Months Ended September 30, 2022 2021 2022 2021 2022 Net income (loss) $ (37.1) $ 36.0 $ (57.6) $ 97.2 $

R1 RCM — FY2022 Earnings Presentation on 6ix